arrow
E

Eva González-Suárez

idibell
H指数:36
被引数:5,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microglia Rank signaling regulates GnRH neuronal function and the hypothalamic-pituitary-gonadal axis

小胶质细胞RANK信号调控GnRH神经元功能及下丘脑-垂体-性腺轴

Science
IF45.8
2026-03-120
PRE
Rank signaling drives basal cell-lineage infidelity leading to mammary tumorigenesis

RANK信号驱动基底细胞谱系不稳定性,导致乳腺肿瘤发生。

2026-02-270
OAAI
Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial

D-BIOMARK临床试验的窗口期研究结果:Denosumab作为免疫调节剂在HER2阴性早期乳腺癌中的应用

2025-05-120
OA
Denosumab as an enhancer of the immune infiltrate in hormone receptor-positive early breast cancer. Subgroup analysis from the D-Biomark window-of-opportunity clinical trial (NCT03691311)
2024-05-020
PRE
Results of the window-of-opportunity clinical trial D-BIOMARK: Study of biomarkers of the antitumor activity of denosumab and its role as a modulator of the immune response in early breast cancer
2023-10-010
PRE
Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

超越想象: 乳腺生物学和乳腺癌研究的最新突破和下一个挑战

2023-07-141
OAAI
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer

RANK是ER阴性绝经后乳腺癌的不良预后标志物和治疗靶点

2023-03-073
OAAI
First results of the randomized window of opportunity clinical trial D-Biomark: Immunomodulatory effect of denosumab in early breast cancer
2022-02-150
PRE
RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness
2021-06-0122
OAAI